未登录Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease
Majid, Oneeb; Cao, Youfang; Willis, Brian A.; Hayato, Seiichi; Takenaka, Osamu; Lalovic, Bojan; Reddy, Sree Harsha Sreerama; Penner, Natasha; Reyderman, Larisa; Yasuda, Sanae; Hussein, Ziad .png)
分享.png)
收藏Population pharmacokinetic-pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC)Majid, Oneeb; Hayato, Seiichi; Reddy, Sree Harsha Sreerama; Lalovic, Bojan; Hihara, Taro; Hoshi, Taisuke; Funahashi, Yasuhiro; Aluri, Jagadeesh; Takenaka, Osamu; Yasuda, Sanae; Hussein, Ziad 分享 收藏 分享 收藏 Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's diseaseMatsuoka, Katsuyoshi; Naganuma, Makoto; Hibi, Toshifumi; Tsubouchi, Hirohito; Oketani, Kiyoshi; Katsurabara, Toshinori; Hojo, Seiichiro; Takenaka, Osamu; Kawano, Tetsu; Imai, Toshio; Kanai, Takanori 分享 收藏 分享 收藏 Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists (vol 22, pg 6071, 2014)Yoshida, Yu; Terauchi, Taro; Naoe, Yoshimitsu; Kazuta, Yuji; Ozaki, Fumihiro; Beuckmann, Carsten T.; Nakagawa, Makoto; Suzuki, Michiyuki; Kushida, Ikuo; Takenaka, Osamu; Ueno, Takashi; Yonaga, Masahiro 分享 收藏 分享 收藏 Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonistsYoshida, Yu; Terauchi, Taro; Naoe, Yoshimitsu; Kazuta, Yuji; Ozaki, Fumihiro; Beuckmann, Carsten T.; Nakagawa, Makoto; Suzuki, Michiyuki; Kushida, Ikuo; Takenaka, Osamu; Ueno, Takashi; Yonaga, Masahiro 分享 收藏 分享 收藏 Discovery of 2-(2-Oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (Perampanel): A Novel, Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropanoic Acid (AMPA) Receptor AntagonistHibi, Shigeki; Ueno, Koshi; Nagato, Satoshi; Kawano, Koki; Ito, Koichi; Norimine, Yoshihiko; Takenaka, Osamu; Hanada, Takahisa; Yonaga, Masahiro 分享 收藏 Perampanel: A novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsyHanada, Takahisa; Hashizume, Yutaka; Tokuhara, Naoki; Takenaka, Osamu; Kohmura, Naohiro; Ogasawara, Aichi; Hatakeyama, Shinji; Ohgoh, Makoto; Ueno, Masataka; Nishizawa, Yukio 分享 收藏 分享 收藏 Synthesis and pharmacological profile of serofendic acids A and BTerauchi, Taro; Asai, Naoki; Doko, Takashi; Taguchi, Ryota; Takenaka, Osamu; Sakurai, Hideki; Yonaga, Masahiro; Kimura, Teiji; Kajiwara, Akiharu; Niidome, Tetsuhiro; Kume, Toshiaki; Akaike, Akinori; Sugimoto, Hachiro 分享 收藏 分享 收藏 E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo [4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitorE3024，3-丁-2-炔基-5-甲基-2-哌嗪-1-基-3，5-二氢-4h-咪唑并 [4，5-d]pyridazin-4-one甲苯磺酸酯，是一种新型，选择性和竞争性的二肽基肽酶-IV抑制剂Yasuda, Nobuyuki; Nagakura, Tadashi; Inoue, Takashi; Yamazaki, Kazuto; Katsutam, Naruo; Takenaka, Osamu; Clark, Richard; Matsuura, Fumiyoshi; Emori, Eita; Yoshikawa, Seiji; Kira, Kazunobu; Ikuta, Hironori; Okada, Toshimi; Saeki, Takao; Asano, Osamu; Tanaka, Isao 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
